U.S. markets closed
  • S&P Futures

    4,564.75
    -11.00 (-0.24%)
     
  • Dow Futures

    34,567.00
    -55.00 (-0.16%)
     
  • Nasdaq Futures

    15,941.00
    -47.50 (-0.30%)
     
  • Russell 2000 Futures

    2,194.60
    -10.60 (-0.48%)
     
  • Crude Oil

    66.78
    +0.28 (+0.42%)
     
  • Gold

    1,769.10
    +6.40 (+0.36%)
     
  • Silver

    22.36
    +0.05 (+0.22%)
     
  • EUR/USD

    1.1297
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • Vix

    27.95
    -3.17 (-10.19%)
     
  • GBP/USD

    1.3285
    -0.0017 (-0.13%)
     
  • USD/JPY

    113.1010
    -0.1080 (-0.10%)
     
  • BTC-USD

    56,536.44
    -775.22 (-1.35%)
     
  • CMC Crypto 200

    1,439.26
    +0.38 (+0.03%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,796.49
    +43.12 (+0.16%)
     

Why Relay Therapeutics Is Up 30% This Week

·2 min read
Why Relay Therapeutics Is Up 30% This Week
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

What happened Shares of Relay Therapeutics (NASDAQ: RLAY), a clinical-stage biopharmaceutical company, have risen about 30% since the stock's closing price last Friday. Investors are highly encouraged by interim clinical trial data that suggest the company's new approach to drug development can produce a new blockbuster cancer treatment.